Acessibilidade / Reportar erro

Covid-19 and Safety in the Cath Lab: Where We Are and Where We Are Headed

Coronavirus; COVID-19; Pandemics; Pathological Conditions, Signs and Symptoms; Fever; Cough; Dyspnea; Fatigue; Diarrhea; Chest Pain; Mental Confusion; Myalgia, Cardiovascular Diseases/complications; Safety

The COVID-19 pandemic, caused by the betacoronavirus SARS-CoV-2, has rapidly spread worldwide from the city of Wuhan, China. Since its beginning, it has affected more than 2,700,000 individuals and caused almost 185,000 deaths in 185 countries, compounding the difficulties in medical healthcare worldwide. By April 23, 2020, Brazil had registered almost 47,000 confirmed cases and 3,000 deaths.11. Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20(5):533-4.

COVID-19 aggravates the inequalities and uncertainties of science in general. This is no different when it comes to the heart. Unlike other epidemics caused by respiratory viruses, COVID-19 affects the heart, not only because most confirmed cases and deaths involve individuals with hypertension, heart failure, arrhythmias and coronary artery disease, but also because the disease is associated with a higher number of cardiac complications, such as myocardial injury, cardiogenic shock, Takotsubo syndrome, pulmonary embolism, myocarditis and arrhythmia.22. Oliveira GMM, Pinto FJ. COVID-19: A Matter Close to the Heart . Int J Cardiovasc Sci. 2020; ahead print. Epub Apr 17,2020. Apart from inflammation, endothelial activation, oxidation of low-density lipoproteins, platelet activation and tissue factor expression caused by respiratory virus epidemics, such as severe acute respiratory syndrome (SARS) and Middle-East respiratory syndrome (MERS), poor COVID-19 prognosis is compounded by the deleterious effect of the association of treatment drugs (chloroquine/azithromycin) that can cause malignant arrhythmias in patients with heart disease.33. Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Bondi-Zoccai G, et al. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic, J Am Coll Cardiol. 2020 Mar 18, Pii:S0735-1097(20)34637-4 [Epub ahead of print]

The challenges concerning COVID-19 are huge, because it tests us all - patients, healthcare personnel, health systems and the general population. In light of this, the importance of the safety of healthcare workers has never been so emphasized.22. Oliveira GMM, Pinto FJ. COVID-19: A Matter Close to the Heart . Int J Cardiovasc Sci. 2020; ahead print. Epub Apr 17,2020.

Working in a hospital during a pandemic of a highly contagious disease, such as COVID-19, reminds healthcare workers of the need to reinforce all safety measures inside a cardiac catheterization laboratory (CCL). That is because, in addition to the cardiovascular alterations due to COVID-19, patients with cardiovascular diseases, such as acute myocardial infarction and advanced structural diseases, continue to require interventional procedures.

Therefore, the safety measures for healthcare professionals and patients become even more important during the COVID-19 pandemic. Some of the safety issues that might affect both patients and healthcare personnel are as follows: ionizing radiation, equipment, and contact with chemical and biological agents. All health professionals in contact with patients should follow the local and national guidelines for infection control and use of personal protective equipment (PPE), which should be available and on hand for all staff members. In addition, strict adherence to all safety rules required for a catheterization procedure indication should be encouraged; moreover, all urgent cases should be prioritized, and all routine cases postponed if this carries no loss to either prognosis or the patients’ quality of life.44. Welt FGP, Shah PB, Aronow HD, Bortnick AE, Henry TD, Sherwood MW, et al., from the American College of Cardiology’s (ACC) Interventional Council and the Society of Cardiovascular Angiography and Intervention (SCAI), Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From ACC’s Interventional Council and SCAI. J Am Coll Cardiol. 2020; doi: https://doi.org/10.1016/j.jacc.2020.03.031.
https://doi.org/10.1016/j.jacc.2020.03.0...

The Brazilian Society of Interventional Cardiology (SBHCI) has published a position statement on some general measures to tackle COVID-19: limitation of social exposure; adoption of stricter personal hygiene habits; home confinement of individuals with the mild form of COVID-19; hospital support with isolation for patients with the severe forms of the disease; quarantine for the close contacts of suspected cases; priority allocation of healthcare resources to urgent and emergent cases; protection of the professionals involved in patients’ care. In addition, regarding specifically the CCL, the SBHCI recommends: to postpone elective procedures in patients with confirmed or suspected COVID-19; to limit the performance of CCL procedures to cardiovascular emergencies, and, for the other cases, procedures must be postponed until the non-infecting stage of disease; in CCLs with multiple procedure rooms, one should be dedicated to the treatment of suspected or confirmed COVID-19 patients.55. Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista. (SBHCI). Comunicado n° 04/2020. Posicionamento da Sociedade Brasleira de Hemodinâmica e Cardiologia Intervencionista sobre a Pandemia COVID-19. [Citado em 2020 Apr 30] Disponível em: sbhci.org/post/comunicado 04-2020 www.sbhci.org.br
www.sbhci.org.br...

During the COVID-19 pandemic, the general safety protocols and those concerning CCL procedures, as well as the safety measures for patients and healthcare personnel need to be reviewed, because that infection increases the requirements for indication and effectiveness of the procedures performed.

Safety measures in the procedure preparation stage

A study conducted in China with 72,314 patients with COVID-19 (44,672 laboratory-confirmed cases, 16,186 suspected cases, and 10,567 clinically diagnosed cases) has reported fever, cough, dyspnea, myalgia, fatigue and diarrhea as the most common symptoms. Other signs and symptoms have been reported, such as sore throat, chest pain, mental confusion, and lethargy. The authors have highlighted that COVID-19 had a benign course in 80% of the cases, and that many patients, although asymptomatic, could carry the virus.66. Wu Z, McGoogan JM. Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China:Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA.2020 Feb 24. [Cited 2020 April 16]. Available from:https: Available from: doi: 10.1001/jama/2020.2448 It is worth noting the importance of the differential diagnosis of dyspnea and fatigue, especially when associated with the other symptoms.

During a respiratory pandemic, patients and their families should be informed about the risks of contamination, despite all additional measures taken to minimize them. Because the number of elective procedures will be drastically reduced during that period, the length of hospital stay is predicted to be the minimum necessary for each protocol consensually elaborated.77. Huh S. How to train health personnel to protect themselves from SARS-CoV-2 (novel coronavirus) infection when caring for a patient or suspected case.J educ Eval Health Prof.2020;17:10. Doi:10.3352/jehp.2020.17.18 Moreover, defining a procedure as elective requires clinical judgement, because postponing it might have effects that will increase the likelihood of decompensation and adverse events during the pandemic, such as in high-risk patients with unstable angina. Therefore, the decision about performing a procedure should be individualized and based on the patient’s risk and benefit analysis.88. Naidu SS, Aronow H, Box L, Daffy PL, Kolansky DM, Kupfer JM. SCAI Expert Consensus Statement: 2016 Best Practices in the Cardiac Catheterization Laboratory: (Endorsed by the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencionista; Affirmation of Value by the Canadian Association of Interventional Cardiology–Association Canadienne de Cardiologie d’intervention)*. Cath Cardiovasc Interv. 2016;88(3):407-23.

Despite the adoption of measures to reduce exposure, healthcare personnel shortage should be anticipated based on the likelihood of the removal of infected, exposed, at-risk and quarantined healthcare personnel. Particular attention should be given to avoid simultaneous exposure of healthcare professionals sharing the same skill set to prevent simultaneous contamination, especially in teaching institutions where the staff usually act together.44. Welt FGP, Shah PB, Aronow HD, Bortnick AE, Henry TD, Sherwood MW, et al., from the American College of Cardiology’s (ACC) Interventional Council and the Society of Cardiovascular Angiography and Intervention (SCAI), Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From ACC’s Interventional Council and SCAI. J Am Coll Cardiol. 2020; doi: https://doi.org/10.1016/j.jacc.2020.03.031.
https://doi.org/10.1016/j.jacc.2020.03.0...
In addition, it is worth emphasizing the importance of reducing as much as possible the circulation in the procedure room to ensure the minimum safety threshold established in CCL procedural protocols.44. Welt FGP, Shah PB, Aronow HD, Bortnick AE, Henry TD, Sherwood MW, et al., from the American College of Cardiology’s (ACC) Interventional Council and the Society of Cardiovascular Angiography and Intervention (SCAI), Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From ACC’s Interventional Council and SCAI. J Am Coll Cardiol. 2020; doi: https://doi.org/10.1016/j.jacc.2020.03.031.
https://doi.org/10.1016/j.jacc.2020.03.0...

It is worth noting that patients with suspected or confirmed COVID-19 should ideally undergo procedures at the end of the day or in CCL rooms dedicated to COVID-19, when available, because of the need for terminal disinfection.44. Welt FGP, Shah PB, Aronow HD, Bortnick AE, Henry TD, Sherwood MW, et al., from the American College of Cardiology’s (ACC) Interventional Council and the Society of Cardiovascular Angiography and Intervention (SCAI), Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From ACC’s Interventional Council and SCAI. J Am Coll Cardiol. 2020; doi: https://doi.org/10.1016/j.jacc.2020.03.031.
https://doi.org/10.1016/j.jacc.2020.03.0...

Patients already intubated represent a lower risk of contamination to healthcare personnel, because they are on closed-loop ventilation. In patients with suspected or confirmed COVID-19 who need orotracheal intubation, this intervention should be performed before arrival to the CCL; in addition, intubation should be considered as early as possible in borderline patients to avoid the need for an urgent procedure and to minimize the contamination of the staff.44. Welt FGP, Shah PB, Aronow HD, Bortnick AE, Henry TD, Sherwood MW, et al., from the American College of Cardiology’s (ACC) Interventional Council and the Society of Cardiovascular Angiography and Intervention (SCAI), Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From ACC’s Interventional Council and SCAI. J Am Coll Cardiol. 2020; doi: https://doi.org/10.1016/j.jacc.2020.03.031.
https://doi.org/10.1016/j.jacc.2020.03.0...

Safety measures concerning the procedures

Healthcare personnel exposure and benefits to patients should be balanced for all interventional procedures. For example, during a respiratory epidemic, for hemodynamically stable patients with COVID19+ and ST-segment elevation myocardial infarction, fibrinolysis might be an alternative according to some authors;66. Wu Z, McGoogan JM. Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China:Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA.2020 Feb 24. [Cited 2020 April 16]. Available from:https: Available from: doi: 10.1001/jama/2020.2448 , 99. Zeng J, Huang J, Pan L. How to balance acute myocardial infarction and COVID-19: the protocols from Sichuan Provincial People's Hospital. Intensive Care Med. 2020 Feb 26. doi: 10.1007/s00134-020-05993-9 however, the length of hospital stay waiting for coronary angioplasty after fibrinolysis should be carefully considered.

It is worth noting that COVID19 is spread via respiratory droplets and contact with surfaces on which the virus can last for long periods, such as cell phone, keyboard, mouse and door handles, thus, the procedure duration should be reduced to a minimum.1010. Koh D. Occupational risks for COVID-19 infection. Occup Med (London). 2020;70(1):3-5. doi:10.1093/occmed/kqaa036 , 1111. Costa I, Bittar C, Rizk S, Araujo Filho AE, Santos KQ, Machado T, et al. The Heart and COVID-19: What cardiologists need to know. Arq Bras Cardiol-diol. 2020; [online].ahead print, PP.0-0. DOI: https://doi.org/10.36660/abc.20200279
https://doi.org/10.36660/abc.20200279...
Moreover, patients with suspected or confirmed COVID-19 should be using a face mask upon arrival to the CCL and continue to use it during procedure preparation and the procedure itself.44. Welt FGP, Shah PB, Aronow HD, Bortnick AE, Henry TD, Sherwood MW, et al., from the American College of Cardiology’s (ACC) Interventional Council and the Society of Cardiovascular Angiography and Intervention (SCAI), Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From ACC’s Interventional Council and SCAI. J Am Coll Cardiol. 2020; doi: https://doi.org/10.1016/j.jacc.2020.03.031.
https://doi.org/10.1016/j.jacc.2020.03.0...

All CCL personnel should wear PPE, including FFP2/N95 respirators, goggles, full face shields, disposable caps, gowns, surgical gloves, and shoe covers, during the entire procedure, because of the potential for those patients’ clinical deterioration and the consequent risk that comes with intubation, aspiration and cardiopulmonary resuscitation. In addition, CCL staff should be well educated in the proper donning and doffing of PPE because of the high likelihood of contamination involved in the process.33. Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Bondi-Zoccai G, et al. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic, J Am Coll Cardiol. 2020 Mar 18, Pii:S0735-1097(20)34637-4 [Epub ahead of print]

4. Welt FGP, Shah PB, Aronow HD, Bortnick AE, Henry TD, Sherwood MW, et al., from the American College of Cardiology’s (ACC) Interventional Council and the Society of Cardiovascular Angiography and Intervention (SCAI), Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From ACC’s Interventional Council and SCAI. J Am Coll Cardiol. 2020; doi: https://doi.org/10.1016/j.jacc.2020.03.031.
https://doi.org/10.1016/j.jacc.2020.03.0...
- 55. Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista. (SBHCI). Comunicado n° 04/2020. Posicionamento da Sociedade Brasleira de Hemodinâmica e Cardiologia Intervencionista sobre a Pandemia COVID-19. [Citado em 2020 Apr 30] Disponível em: sbhci.org/post/comunicado 04-2020 www.sbhci.org.br
www.sbhci.org.br...

It is worth noting that myocardial injury has been reported in 7% of the patients with COVID-19 and might correspond to type 2 myocardial infarction or myocarditis.1111. Costa I, Bittar C, Rizk S, Araujo Filho AE, Santos KQ, Machado T, et al. The Heart and COVID-19: What cardiologists need to know. Arq Bras Cardiol-diol. 2020; [online].ahead print, PP.0-0. DOI: https://doi.org/10.36660/abc.20200279
https://doi.org/10.36660/abc.20200279...
Thus, no effort should be spared in reaching the differential diagnosis before the procedure with the aid of imaging tests, such as point-of-care echocardiography.

In addition, it is worth emphasizing that percutaneous coronary intervention should only be performed to the culprit vessel, unless a nonculprit lesion is deemed unstable or in the presence of multiple culprit lesions.1212. Szerlip M, Anwaruddin S, Aronow HD, Cohen MG, Daniels MJ, et al. Considerations for Cardiac Catheterization Laboratory Procedures Dur-ing the COVID-19 Pandemic. Perspectives from the Society for Cardiovascular Angi-ography and Interventions Emerging Leader Mentorship (SCAI ELM) Members and Grad-uates. doi: 10.1002/ccd.28887

Post-procedure safety measures

During the pandemic, in anticipation of a surge in hospitalization required for COVID-19 infected patients and because not only most inpatient beds will be made available for COVID-19 treatment, but also to avoid additional contamination, hospital discharge will occur earlier for stable patients who might be followed up via telemedicine.1212. Szerlip M, Anwaruddin S, Aronow HD, Cohen MG, Daniels MJ, et al. Considerations for Cardiac Catheterization Laboratory Procedures Dur-ing the COVID-19 Pandemic. Perspectives from the Society for Cardiovascular Angi-ography and Interventions Emerging Leader Mentorship (SCAI ELM) Members and Grad-uates. doi: 10.1002/ccd.28887

Within the CCL, all nonessential equipment should be moved out of the procedure room or covered with clear drapes before patient’s arrival to the room, and the same applies to the control and post-procedure recovery rooms. After a procedure in a patient with COVID-19, thorough terminal disinfection can be performed with ultraviolet light.1212. Szerlip M, Anwaruddin S, Aronow HD, Cohen MG, Daniels MJ, et al. Considerations for Cardiac Catheterization Laboratory Procedures Dur-ing the COVID-19 Pandemic. Perspectives from the Society for Cardiovascular Angi-ography and Interventions Emerging Leader Mentorship (SCAI ELM) Members and Grad-uates. doi: 10.1002/ccd.28887

The standard positive pressure ventilation system of the CCL consists of an air-handling unit that distributes conditioned air to different functional units, including the procedure, post-procedure, and control rooms. Positive pressure with adequate air changes can rapidly eliminate the virus from the environment; in addition the risk of cross-contamination from airborne infections has been shown to be low if the personnel is protected with appropriate PPE.99. Zeng J, Huang J, Pan L. How to balance acute myocardial infarction and COVID-19: the protocols from Sichuan Provincial People's Hospital. Intensive Care Med. 2020 Feb 26. doi: 10.1007/s00134-020-05993-9 The positive pressure ventilation system should be extended to the rooms associated with the procedure.

It is worth noting that the inflammatory state of patients with COVID-19 often determines a hypercoagulable condition that requires additional use of heparin.1111. Costa I, Bittar C, Rizk S, Araujo Filho AE, Santos KQ, Machado T, et al. The Heart and COVID-19: What cardiologists need to know. Arq Bras Cardiol-diol. 2020; [online].ahead print, PP.0-0. DOI: https://doi.org/10.36660/abc.20200279
https://doi.org/10.36660/abc.20200279...

Figure 1 shows the safety recommendations for CCL procedures during the COVID-19 pandemic. Those written in bold letters should receive special attention during the COVID-19 pandemic.

Figure 1
– Safety recommendations for cardiac catheterization laboratory (CCL) procedures during the COVID-19 pandemic. The recommendations written in bold letters apply specifically to the COVID-19 pandemic.3-5,7,8,10-14, 27,28

Safety and protective measures for healthcare workers

During the COVID-19 pandemic, all material used for invasive procedures, including the equipment for anesthesia, orotracheal intubation and mechanical ventilation, in addition to PPEs, should undergo a daily check and be readily available for easy and rapid use to minimize the work and burnout of healthcare professionals.1313. Tarantini G, Fraccaro C, Chieffo A, Marchese A, Tarantino F, Rigattieri S, et al. Italian Society of Interventional Cardiology (GISE) position paper for Cath lab-specific preparedness recommendations for healthcare providers in case of suspected, probable or confirmed cases of COVID-19. Catheter Cardiovasc Interv. 2020; 1–5. https://doi.org/10.1002/ccd.28888
https://doi.org/10.1002/ccd.28888...

The PPE should be removed preferably in an anteroom. If no anteroom is available, doffing of PPE should be done inside the procedure room, at the end of the procedure and after the patient has been transferred away, except for the PPE for respiratory protection, which must be removed outside the procedure room.1313. Tarantini G, Fraccaro C, Chieffo A, Marchese A, Tarantino F, Rigattieri S, et al. Italian Society of Interventional Cardiology (GISE) position paper for Cath lab-specific preparedness recommendations for healthcare providers in case of suspected, probable or confirmed cases of COVID-19. Catheter Cardiovasc Interv. 2020; 1–5. https://doi.org/10.1002/ccd.28888
https://doi.org/10.1002/ccd.28888...

Post-procedure visits should be performed by the lowest number possible of professionals; moreover, discussions about additional management should be converted to an online or telephone format, and the same applies to morning CCL rounds.1212. Szerlip M, Anwaruddin S, Aronow HD, Cohen MG, Daniels MJ, et al. Considerations for Cardiac Catheterization Laboratory Procedures Dur-ing the COVID-19 Pandemic. Perspectives from the Society for Cardiovascular Angi-ography and Interventions Emerging Leader Mentorship (SCAI ELM) Members and Grad-uates. doi: 10.1002/ccd.28887

13. Tarantini G, Fraccaro C, Chieffo A, Marchese A, Tarantino F, Rigattieri S, et al. Italian Society of Interventional Cardiology (GISE) position paper for Cath lab-specific preparedness recommendations for healthcare providers in case of suspected, probable or confirmed cases of COVID-19. Catheter Cardiovasc Interv. 2020; 1–5. https://doi.org/10.1002/ccd.28888
https://doi.org/10.1002/ccd.28888...
- 1414. ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic. Eur Soc Cardiol. 2020 Apr 21. [Cited in 2020 April 21]. Available from: https://www.escardio.org/Education/COVID-19-and-Cardiology/ESC-COVID-19-Guidance
https://www.escardio.org/Education/COVID...

Most sanitizers contain alcohol at different concentrations and are used for cleaning and disinfecting high-touch surfaces (floor, walls, ceiling, and countertops), a precaution that is important during the COVID-19 pandemic. SARS-CoV-2, a single-strand RNA virus, is sensitive to ultraviolet radiation and heat, being inactivated by lipid solvents, such as ether (75%), ethanol, sanitizers containing chlorine, peroxyacetic acid and chloroform, except for chlorhexidine.1515. Shereen MA, Shereen MA, khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. J Adv Res. 2020;24:91-8. doi.org/10.1016/j.jare.2020.03.005

Terminal disinfection of the procedure room at the end of each procedure is highly recommended during the COVID-19 pandemic. Disposable PPE, sheets, fabric, and sponges contaminated with blood should be placed into a waste container marked with the biological hazard symbol and disposed into a waste bin labeled as ‘COVID-19’.1010. Koh D. Occupational risks for COVID-19 infection. Occup Med (London). 2020;70(1):3-5. doi:10.1093/occmed/kqaa036

Figure 2 shows the general safety items for CCL procedures. Those written in bold letters should receive special attention during the COVID-19 pandemic.

Figure 2
General safety items for cardiac catheterization laboratory (CCL) procedures during the COVID-19 pandemic. The recommendations written in bold letters apply to the COVID-19 pandemic.3-5,7,8,10-13-28

Figure 3 shows the steps for putting on and removing PPE for CCL procedures during the COVID-19 pandemic.

Figure 3
– Steps for putting on and removing PPE for cardiac catheterization laboratory (CCL) procedures during the COVID-19 pandemic.4,5,12-14,28

A recent case series of 5700 inpatients with COVI-19 (median age, 63 years; male sex, 60.3%) in the city of New York, United States, has reported a high prevalence of comorbidities, especially cardiovascular ones, as follows: arterial hypertension, 56.6%; coronary artery disease, 11.1%; heart failure, 6.9%; obesity, 41.7%; and diabetes, 33.8%. In-hospital lethality rate was 21%, which increased to 88% among those requiring mechanical ventilation. In addition, the authors have reported that most patients maintained their routine medications, such as angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers. These data reinforce the need to maintain the traditional treatment of patients with heart diseases to avoid decompensation during the pandemic.2929. Richardson S; Hirsch JS, Mangala N, Crawford JM, McGinn T, Davidson K, and Northwell COVID-19 Research Consortium. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the NewYork City Area. JAMA. 2020 Apr 22 doi:10.1001/jama.2020.6775

The challenges presented during the COVID-19 pandemic are huge, not only the approach of patients with cardiovascular diseases, who need to continue their treatments regardless of having or not COVID-19, but also the management of the complex cardiovascular manifestations of SARS-CoV-2 infection, such as myocarditis, Takotsubo syndrome and myocardial injury, which can mimic ST-segment elevation myocardial infarction. In addition, patients usually delay seeking hospital treatment because of fear of contamination.3030. Rosenbaum L. The Untold Toll — The Pandemic’s Effects on Patients without Covid. N Engl J Med. 2020 Apr 17. Doi:10.1056/NEJMms2009984 , 3131. Mahmud E, Dauerman HL, Welt FG, Messenger JC, Rao SV, Grines C, et al. Management of acute myocardial infarction during the COVID-19 pandemic,. J Am Coll Cardiol. 2020 April 20. doi: https://doi.org/10.1016/j.jacc.2020.04.039.
https://doi.org/10.1016/j.jacc.2020.04.0...

During the COVID-19 pandemic, the established strategies, such as primary angioplasty, remain the standard treatment. These strategies should be performed at hospitals that are well equipped for a timely response and that have a team of specialized professionals wearing the aforementioned PPEs. The fibrinolysis-based strategy should be reserved for situations in which primary angioplasty cannot be performed.3131. Mahmud E, Dauerman HL, Welt FG, Messenger JC, Rao SV, Grines C, et al. Management of acute myocardial infarction during the COVID-19 pandemic,. J Am Coll Cardiol. 2020 April 20. doi: https://doi.org/10.1016/j.jacc.2020.04.039.
https://doi.org/10.1016/j.jacc.2020.04.0...

Although interventional cardiology certainly entails more engaging topics than safety, extraordinary times call for extraordinary measures. It is essential to revisit the different aspects of protection for patients and healthcare personnel in the CCL, as well as to tailor them to the COVID-19 scenario.

Health systems around the world have been overwhelmed for months. However, unlike ventilators and wards, healthcare personnel cannot be ‘manufactured’ urgently, mainly highly specialized professionals, such as CCL staff.3232. McCartney M. Medicine: before COVID-19, and after. The art of medicine-perspectives. Lancet. 2020 Ar 20;395(10232):1248-9.

All activities performed in CCL rooms need to be restructured, and registries should be kept to quantify the effects of COVID-19 on the treatment of patients with cardiovascular diseases. In doing so, we will be able to learn from this pandemic and thereby both add value to this field and contribute to a rapidly growing body of knowledge on COVID-19.

References

  • 1
    Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20(5):533-4.
  • 2
    Oliveira GMM, Pinto FJ. COVID-19: A Matter Close to the Heart . Int J Cardiovasc Sci. 2020; ahead print. Epub Apr 17,2020.
  • 3
    Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Bondi-Zoccai G, et al. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic, J Am Coll Cardiol. 2020 Mar 18, Pii:S0735-1097(20)34637-4 [Epub ahead of print]
  • 4
    Welt FGP, Shah PB, Aronow HD, Bortnick AE, Henry TD, Sherwood MW, et al., from the American College of Cardiology’s (ACC) Interventional Council and the Society of Cardiovascular Angiography and Intervention (SCAI), Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From ACC’s Interventional Council and SCAI. J Am Coll Cardiol. 2020; doi: https://doi.org/10.1016/j.jacc.2020.03.031
    » https://doi.org/10.1016/j.jacc.2020.03.031
  • 5
    Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista. (SBHCI). Comunicado n° 04/2020. Posicionamento da Sociedade Brasleira de Hemodinâmica e Cardiologia Intervencionista sobre a Pandemia COVID-19. [Citado em 2020 Apr 30] Disponível em: sbhci.org/post/comunicado 04-2020 www.sbhci.org.br
    » www.sbhci.org.br
  • 6
    Wu Z, McGoogan JM. Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China:Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA.2020 Feb 24. [Cited 2020 April 16]. Available from:https: Available from: doi: 10.1001/jama/2020.2448
  • 7
    Huh S. How to train health personnel to protect themselves from SARS-CoV-2 (novel coronavirus) infection when caring for a patient or suspected case.J educ Eval Health Prof.2020;17:10. Doi:10.3352/jehp.2020.17.18
  • 8
    Naidu SS, Aronow H, Box L, Daffy PL, Kolansky DM, Kupfer JM. SCAI Expert Consensus Statement: 2016 Best Practices in the Cardiac Catheterization Laboratory: (Endorsed by the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencionista; Affirmation of Value by the Canadian Association of Interventional Cardiology–Association Canadienne de Cardiologie d’intervention)*. Cath Cardiovasc Interv. 2016;88(3):407-23.
  • 9
    Zeng J, Huang J, Pan L. How to balance acute myocardial infarction and COVID-19: the protocols from Sichuan Provincial People's Hospital. Intensive Care Med. 2020 Feb 26. doi: 10.1007/s00134-020-05993-9
  • 10
    Koh D. Occupational risks for COVID-19 infection. Occup Med (London). 2020;70(1):3-5. doi:10.1093/occmed/kqaa036
  • 11
    Costa I, Bittar C, Rizk S, Araujo Filho AE, Santos KQ, Machado T, et al. The Heart and COVID-19: What cardiologists need to know. Arq Bras Cardiol-diol. 2020; [online].ahead print, PP.0-0. DOI: https://doi.org/10.36660/abc.20200279
    » https://doi.org/10.36660/abc.20200279
  • 12
    Szerlip M, Anwaruddin S, Aronow HD, Cohen MG, Daniels MJ, et al. Considerations for Cardiac Catheterization Laboratory Procedures Dur-ing the COVID-19 Pandemic. Perspectives from the Society for Cardiovascular Angi-ography and Interventions Emerging Leader Mentorship (SCAI ELM) Members and Grad-uates. doi: 10.1002/ccd.28887
  • 13
    Tarantini G, Fraccaro C, Chieffo A, Marchese A, Tarantino F, Rigattieri S, et al. Italian Society of Interventional Cardiology (GISE) position paper for Cath lab-specific preparedness recommendations for healthcare providers in case of suspected, probable or confirmed cases of COVID-19. Catheter Cardiovasc Interv. 2020; 1–5. https://doi.org/10.1002/ccd.28888
    » https://doi.org/10.1002/ccd.28888
  • 14
    ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic. Eur Soc Cardiol. 2020 Apr 21. [Cited in 2020 April 21]. Available from: https://www.escardio.org/Education/COVID-19-and-Cardiology/ESC-COVID-19-Guidance
    » https://www.escardio.org/Education/COVID-19-and-Cardiology/ESC-COVID-19-Guidance
  • 15
    Shereen MA, Shereen MA, khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. J Adv Res. 2020;24:91-8. doi.org/10.1016/j.jare.2020.03.005
  • 16
    Andreassi MG, Picalluga E, Guagliumi G, Del Greco M, Gaita F, Picano F. Occupational health risks in cardiac catheterization laboratory workers. Circ Cardiovasc Interv. 2016; 9(4):e003273.
  • 17
    Christopoulos G, Makke L, Kolsia A, Rangan BV, Roesle M. Optimizing Radiation Safety in the Cardiac Catheterization Laboratory: A Practical Approach. Catheter Cardiovasc Interv. 2016;87(2):291-301.
  • 18
    Sun Z, Abazis A, Yusof AK. Radiation-induced noncancer risks in interventional cardiology: optimisation of procedures and staff and patient dose reduction. Biomed Res Int. 2013;2013.976962
  • 19
    Fetterly KA, Mathew V, Lennon R, Bell MR, Holmes DR Jr, Rihal CS, et al. Radiation Dose Reduction in the Invasive Cardiovascular Laboratory Implementing a Culture and Philosophy of Radiation Safety. JACC:Cardiovasc Interv. 2012;5(8):866-73.
  • 20
    Agarwal S, Parashar A, Ellis SG, Heupler FA Jr, Lau E, Tuzcu EM, et al. Measures to reduce radiation in a modern cardiac catheterization laboratory. Circ Cardiovasc Interv, 2014;7(4):447-55.
  • 21
    Agência Nacional de Vigilância Sanitária. (Anvisa). Gerência de Vigilância e Monitoramento em Serviços de Saúde Gerência Geral de Tecnologia em Serviços de Saúde. Nota Técnica GVIMS/GGTES/Anvisa No 04/2020 orientações para serviços de saúde: medidas de prevenção e controle que devem ser adotadas durante a assistência aos casos suspeitos ou confirmados de infecção pelo novo coronavirus (SARS-COV-2); 31 mar. 2020.
  • 22
    Best PJ, Skelding KA, Mehran R, Chieffo A, Kunadian V, Madan M, et al. SCAI Consensus Document on Occupational Radiation Exposure to the Pregnant Cardiologist and Technical Personnel. Catheter Cardiovasc Interv. 2011 Feb 1;77(2):232-41.
  • 23
    Gurm HS, Dixon SR, Smith DE, Share D, Lafonde T, Greenbaum A, et al. Renal Function-Based Contrast Dosing to Define Safe Limits of Radiographic Contrast Media in Patients Undergoing Percutaneous Coronary Interventions. J Am Coll Cardiol. 2011;58(9):907-14.
  • 24
    Kern M. Cath Lab Safety. CathLabDigest. 2020 Apr 24;22(4)
  • 25
    Picano E. The appropriate and justified use of medical radiation in cardiovascular imaging: a position document of the ESC Associations of Cardiovascular Imaging, Percutaneous Cardiovascular Interventions and Electrophysiology. Eur Heart J. 2014; 35(10):865-72.
  • 26
    Azzalini L, Laricchia A, Regazzoli D, Mitomo S, Hachinohe D, Bellini B, et al. Ultra-Low Contrast Percutaneous Coronary Intervention to Minimize the Risk for Contrast-Induced Acute Kidney Injury in Patients With Severe Chronic Kidney Disease. J Invasive Cardiol. 2019 Jun;31(6):176-82. Epub 2019 Mar 15
  • 27
    Romaguera R, Gonzalez IC, Ojeda S, Jimenez-Candil J, Calvo D, Garcia Seara J, et al. Gestión de salas de procedimientos invasivos cardiológicos durante el brote de coronavirus COVID-19. Documento de consenso de la Asociación de Cardiología Intervencionista y la Asociación del Ritmo Cardiaco de la Sociedad Española de Cardiología Rafael Romagueraa. REC Interv Cardiol. REC Interv Cardiol. 2020; ahead print. Epub Mar 16,2020. doi: https://doi.org/10.24875/RECIC.M20000114
    » https://doi.org/10.24875/RECIC.M20000114
  • 28
    Ierardi AM, Wood BJ, Gaudino C, Angileri SA, Jones EC, Hauseggers K, et al. How to Handle a COVID-19 Patient in the Angiographic Suite. Cardiovasc Intervent Radiol. 2020 Apr 10. doi: https://doi.org/10.1007/s00270-020-02476-8
    » https://doi.org/10.1007/s00270-020-02476-8
  • 29
    Richardson S; Hirsch JS, Mangala N, Crawford JM, McGinn T, Davidson K, and Northwell COVID-19 Research Consortium. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the NewYork City Area. JAMA. 2020 Apr 22 doi:10.1001/jama.2020.6775
  • 30
    Rosenbaum L. The Untold Toll — The Pandemic’s Effects on Patients without Covid. N Engl J Med. 2020 Apr 17. Doi:10.1056/NEJMms2009984
  • 31
    Mahmud E, Dauerman HL, Welt FG, Messenger JC, Rao SV, Grines C, et al. Management of acute myocardial infarction during the COVID-19 pandemic,. J Am Coll Cardiol. 2020 April 20. doi: https://doi.org/10.1016/j.jacc.2020.04.039
    » https://doi.org/10.1016/j.jacc.2020.04.039
  • 32
    McCartney M. Medicine: before COVID-19, and after. The art of medicine-perspectives. Lancet. 2020 Ar 20;395(10232):1248-9.
  • Study Association
    This study is not associated with any graduation program.
  • Sources of Funding
    There were no external funding sources for this study.

Publication Dates

  • Publication in this collection
    29 May 2020
  • Date of issue
    May-Jun 2020

History

  • Received
    23 Apr 2020
  • Reviewed
    25 Apr 2020
  • Accepted
    26 Apr 2020
Sociedade Brasileira de Cardiologia Avenida Marechal Câmara, 160, sala: 330, Centro, CEP: 20020-907, (21) 3478-2700 - Rio de Janeiro - RJ - Brazil
E-mail: revistaijcs@cardiol.br